Hypertension and Cardiovascular Risk Factors
NCT00171782 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 76
Last updated 2023-10-12
Summary
A study to evaluate the efficacy of valsartan+chydochlorothiazide in patients with stage 2 hypertension and cardiovascular risk factors.
Conditions
Interventions
- DRUG
-
VALSARTAN+HYDROCHLOROTHIAZIDE
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Novartis Pharmaceuticals · Novartis Pharmaceuticals
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2004-02-29
- Primary Completion
- 2004-12-31
- Completion
- 2004-12-31
More Related Trials
-
Valsartan/Hydrochlorothiazide Combination in Hypertensive Patients Not Controlled With Valsartan Alone
NCT00170989 ·Status: COMPLETED ·Phase: PHASE3
-
Valsartan/Hydrochlorothiazide Combination in the Treatment of Severe Hypertension
NCT00273299 ·Status: COMPLETED ·Phase: PHASE3
-
Safety/Efficacy of Valsartan/Hydrochlorothiazide Combination Compared to Hydrochlorothiazide in Obese Hypertensive Adults
NCT00439738 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of Valsartan Versus Amlodipine in Postmenopausal Women With Hypertension
NCT00171054 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of Two Treatment Strategies in Hypertensive Patients
NCT00171444 ·Status: COMPLETED ·Phase: PHASE4
-
To Find Out Whether Valsartan With or Without Other Blood Pressure Medications Would Improve the Ability of the Heart to Fill and Empty, and the Ability of the Heart Muscle to Relax Adequately in People With High Blood Pressure.
NCT00170924 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Describe Vascular and Renal Effects and Safety of Valsartan in Patients With High Blood Pressure
NCT00171353 ·Status: COMPLETED ·Phase: PHASE4
-
The VALIDATE Study of Valsartan for Patients With Early Stage Heart Failure
NCT00241098 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of Valsartan Plus Hydrochlorothiazide in Fixed Dose Combination in Hypertensive Patients Not Controlled by the Free Combination of an Angiotensin Receptor Blocker Plus Hydrochlorothiazide
NCT00360178 ·Status: COMPLETED ·Phase: PHASE3
-
Valsartan/Hydrochlorothiazide Combination vs Amlodipine in Patients With Hypertension, Diabetes, and Albuminuria.
NCT00171561 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Efficacy of Valsartan Plus Hydrochlorothiazide and Amlodipine in Hypertensive Patients
NCT00426478 ·Status: COMPLETED ·Phase: PHASE4
-
Valsartan Intensified Primary Care Reduction of Blood Pressure Study
NCT00902304 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of Valsartan/Hydrochlorothiazide Versus Amlodipine and Hydrochlorothiazide in Patients Hypertension
NCT00425997 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy & Safety of Orally Administered Valsartan/Amlodipine Combo Therapy vs Amlodipine Monotherapy in Patients With Stage II Hypertension
NCT00350168 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy & Safety of Orally Administered Valsartan/Amlodipine Combo Therapy vs Amlodipine Monotherapy in Black Patients With Stage II Hypertension
NCT00353912 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Compare Treating Hypertension With Valsartan 160 MG to Valsartan 320 Mg
NCT00241137 ·Status: COMPLETED ·Phase: PHASE3
-
Effectiveness of a Valsartan Based vs an Amlodipine Based Treatment Strategy in naïve Patients With Stage 1 or Stage 2 Hypertension or in Patients Uncontrolled on Current Monotherapy
NCT00351130 ·Status: COMPLETED ·Phase: PHASE4
-
VALORY Study of Valsartan/Hydrochlorizide for Patients Who do Not Respond Adequately to Olmesartan Medoxomil
NCT00171015 ·Status: COMPLETED ·Phase: PHASE3
-
Long Term Study of VAH631 in Patients With Essential Hypertension (Extension From B1303 Study)
NCT00338936 ·Status: COMPLETED ·Phase: PHASE3
-
A Study Of Valsartan Used To Treat Hypertension For Up To 13 Months In Hypertensive Children Ages 6 - 16 Years Of Age
NCT00171041 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Valsartan and the Combination of Valsartan and Simvastatin
NCT00385931 ·Status: COMPLETED ·Phase: PHASE3
-
A Study Of Valsartan Used To Treat Hypertension For Up To 56 Weeks In Children Ages 1 - 5 Years Who Have Hypertension
NCT00171028 ·Status: COMPLETED ·Phase: PHASE3
-
A 10-12 Week Study to Evaluate the Safety and Efficacy of 320 mg Valsartan and 80 mg Simvastatin in Combination and as Monotherapies in Treating Hypertension and Hypercholesterolemia
NCT00171093 ·Status: COMPLETED ·Phase: PHASE3
-
Effectiveness of a Valsartan Based Versus an Amlodipine Based Treatment Strategy in naïve Patients With Stage 1 or Stage 2 Hypertension or in Patients Uncontrolled on Current Monotherapy
NCT00304226 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of Valsartan and Nebivolol/Valsartan in Hypertensive Patients With LVH
NCT03180593 ·Status: COMPLETED ·Phase: PHASE4